A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro
- PMID: 7715611
- DOI: 10.1007/BF00996356
A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro
Abstract
A retinoic acid (RA) inducible skin-specific gene transcript (RIS-1) was isolated by differential hybridization screening of a RA-treated human skin cDNA library. The library was constructed from pooled RNA derived from normal adult human skin treated with all trans-RA for 4 h (n = 6) and 12 h (n = 6) in vivo. RIS-1 cDNA corresponded to a 0.6 kb transcript that was barely detectable in normal adult human skin but was significantly induced by 8 h in RA-treated compared to vehicle-treated skin (range 1.1-3.6 fold). Prolonged RA treatment for up to 24 h further increased relative RIS-1 mRNA levels by 1.3-5.5 fold. HPLC analysis of the RA content of 0.1% RA-treated skin in vivo revealed significant levels at 6 h (18.8-120.6 ng RA/g wet weight tissue; approximately 240 nM), immediately preceding the time point at which the increased RIS-1 mRNA level was first seen. This concentration of RA also induced the mRNA levels for cellular RA binding protein II (1.6-19 fold), a marker of RA activity in human skin. RIS-1 mRNA was detected by Northern and dot blotting only in normal skin but not in any other normal human tissues examined, indicating a tissue-specific pattern of gene expression. RIS-1 transcripts were detected at very low levels in untreated cultured human epidermal keratinocytes, while no expression was seen in dermal fibroblasts and melanocytes, the other major cell types in skin. Southern analysis of human and mouse DNA indicated the existence of evolutionarily conserved sequences for RIS-1 between these two species. The polypeptide sequence derived from the partial RIS-1 cDNA was found to be identical to the calcium binding domain found in 'psoriasin', a gene whose expression appears to be increased in the skin of psoriasis patients.
Similar articles
-
Topical all-trans retinoic acid (RA) induces an early, coordinated increase in RA-inducible skin-specific gene/psoriasin and cellular RA-binding protein II mRNA levels which precedes skin erythema.Arch Dermatol Res. 1996 Oct;288(11):664-9. doi: 10.1007/BF02505275. Arch Dermatol Res. 1996. PMID: 8931868
-
Retinoic acid induces expression of PA-FABP (psoriasis-associated fatty acid-binding protein) gene in human skin in vivo but not in cultured skin cells.Exp Dermatol. 1994 Oct;3(5):212-8. doi: 10.1111/j.1600-0625.1994.tb00279.x. Exp Dermatol. 1994. PMID: 7881766
-
Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation.J Invest Dermatol. 1995 Oct;105(4):549-56. doi: 10.1111/1523-1747.ep12323445. J Invest Dermatol. 1995. PMID: 7561157 Clinical Trial.
-
Topical retinoic acid alters the expression of cellular retinoic acid-binding protein-I and cellular retinoic acid-binding protein-II in non-lesional but not lesional psoriatic skin.Exp Dermatol. 2002 Apr;11(2):143-52. doi: 10.1034/j.1600-0625.2002.110206.x. Exp Dermatol. 2002. PMID: 11994141
-
Psoriasin and its allergenic bovine homolog Bos d 3.Cell Mol Life Sci. 2006 May;63(10):1091-4. doi: 10.1007/s00018-005-5598-x. Cell Mol Life Sci. 2006. PMID: 16612562 Free PMC article. Review.
Cited by
-
Current use and future potential role of retinoids in dermatology.Drugs. 1997 Mar;53(3):358-88. doi: 10.2165/00003495-199753030-00003. Drugs. 1997. PMID: 9074840 Review.
-
Psoriasin (S100A7) expression is altered during skin tumorigenesis.BMC Dermatol. 2003 Feb 24;3:1. doi: 10.1186/1471-5945-3-1. Epub 2003 Feb 24. BMC Dermatol. 2003. PMID: 12600274 Free PMC article.
-
RIS-1/psoriasin expression in epithelial skin cells indicates their selective role in innate immunity and in inflammatory skin diseases including acne.Dermatoendocrinol. 2017 Oct 4;9(1):e1338993. doi: 10.1080/19381980.2017.1338993. eCollection 2017. Dermatoendocrinol. 2017. PMID: 29484089 Free PMC article.
-
S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.Cancer Gene Ther. 2016 Nov;23(11):382-391. doi: 10.1038/cgt.2016.43. Epub 2016 Oct 21. Cancer Gene Ther. 2016. PMID: 27767088
-
Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity.Cancer Cell Int. 2015 Jul 29;15:74. doi: 10.1186/s12935-015-0226-9. eCollection 2015. Cancer Cell Int. 2015. Retraction in: Cancer Cell Int. 2021 Feb 01;21(1):82. doi: 10.1186/s12935-021-01786-2. PMID: 26225121 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials